Quidel (QDEL) Scheduled to Post Earnings on Wednesday
Quidel (NASDAQ:QDEL) is scheduled to be announcing its earnings results after the market closes on Wednesday, February 21st. Analysts expect the company to announce earnings of $0.20 per share for the quarter.
Quidel (QDEL) opened at $44.31 on Wednesday. The company has a current ratio of 6.28, a quick ratio of 5.68 and a debt-to-equity ratio of 0.70. The firm has a market cap of $1,510.00, a P/E ratio of -276.94, a P/E/G ratio of 1.39 and a beta of 1.02. Quidel has a 1 year low of $19.97 and a 1 year high of $49.47.
In other Quidel news, CEO Douglas C. Bryant sold 36,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 30th. The shares were sold at an average price of $37.36, for a total value of $1,344,960.00. Following the completion of the transaction, the chief executive officer now owns 296,493 shares of the company’s stock, valued at approximately $11,076,978.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Douglas C. Bryant sold 12,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $36.72, for a total transaction of $440,640.00. Following the completion of the transaction, the chief executive officer now directly owns 296,493 shares of the company’s stock, valued at approximately $10,887,222.96. The disclosure for this sale can be found here. Insiders sold a total of 370,260 shares of company stock valued at $15,293,980 in the last three months. 22.00% of the stock is currently owned by corporate insiders.
Quidel Company Profile
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.
Receive News & Ratings for Quidel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel and related companies with MarketBeat.com's FREE daily email newsletter.